A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

Completed · Not applicable · Has a placebo group

Conditions studied: Pancreatitis

In brief

The purpose of this study is to determine if giving Aprepitant 4 hours before and for two days after ERCP decreases the risk of developing pancreatitis after ERCP.

Key facts

Study ID

NCT00736073

Run by

Duke University

People needed

73

Starts

2007-08-01

Expected to finish

2012-11-01

Last updated by the study team

2015-06-22

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• active pancreatitis
• if they are pregnant
• known adverse reaction to aprepitant

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.